Can-Fite BioPharma CANF
NYSE CANF
$1.92 +0.03 (+1.60%)
As of: Oct 20, 2026 · 1:06 PM EDT

Can-Fite BioPharma (CANF) EBITDA (2012 - 2013)

Updated

Can-Fite BioPharma's EBITDA came in at -$9.93 million for FY2025, compared with -$8.12 million in FY2024.

Analysis

Can-Fite BioPharma (CANF) EBITDA (2012 - 2013) Analysis & Trends

Going back to FY2015, Can-Fite BioPharma's EBITDA data covers 11 years.

  • The FY2025 figure represents the lowest annual EBITDA since FY2021.
  • Per Business Quant, earlier years put EBITDA at -$8.12 million in FY2024, -$8.18 million in FY2023, -$8.18 million in FY2022 and -$12.83 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 9.10 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 8.33 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 5.09 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -9.70 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 5.89 Bn
10 Can-Fite BioPharma 1.58 Mn -18.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 3.28 Mn
Sep 30, 2013 1.55 Mn
Jun 30, 2013 2.20 Mn
Dec 31, 2012 1.85 Mn
Sep 30, 2012 1.19 Mn
Jun 30, 2012 1.51 Mn
API Access

Can-Fite BioPharma EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=CANF&period=max&api_key=YOUR_API_KEY